title: Successful treatment of chronic mucocutaneous candidiasis caused by azole-resistant Candida albicans with posaconazole.
abstract: Refractory or recurrent infections of skin, nails, and the mucous membranes are clinical signs of chronic mucocutaneous candidiasis, frequently associated with immunological defects. Here we describe a 39-years-old female patient, with familial CMC, that presented with an extensive infection caused by an azole-resistant Candida albicans isolate, successfully treated with posaconazole.
authors.affiliation: Department of Internal Medicine, Allergy and Clinical Immunology, Azienda Ospedaliero Universitaria, University of Cagliari, SS 554- Bivio Sestu, 09042 Monserrato, Cagliari, Italy. davidefirinu@yahoo.it
authors.forename: Davide
authors.initials: D
authors.lastname: Firinu
authors.forename: Orietta
authors.initials: O
authors.lastname: Massidda
authors.forename: Maria Maddalena
authors.initials: MM
authors.lastname: Lorrai
authors.forename: Loredana
authors.initials: L
authors.lastname: Serusi
authors.forename: Monica
authors.initials: M
authors.lastname: Peralta
authors.forename: Maria Pina
authors.initials: MP
authors.lastname: Barca
authors.forename: Paolo
authors.initials: P
authors.lastname: Serra
authors.forename: Paolo Emilio
authors.initials: PE
authors.lastname: Manconi
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D002176:Candida albicans / Q000472:pathogenicity; D002178:Candidiasis, Chronic Mucocutaneous / Q000188:drug therapy / Q000276:immunology; D025141:Drug Resistance, Fungal; D005260:Female; D006801:Humans; D016896:Treatment Outcome; D014230:Triazoles / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000935:Antifungal Agents; D014230:Triazoles; C101425:posaconazole